SEARCH

SEARCH BY CITATION

References

  • Anderson, Jr, F.A., Wheeler, H.B., Goldberg, R.J., Hosmer, D.W., Patwardhan, N.A., Jvanovic, B., Forcier, A. & Dalen, J.E. (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Archives of Internal Medicine, 15, 933938.
  • Bank, I., Libourel, E.J., Middeldorp, S., Hamulyak, K., Van Pampus, E.C., Koopman, M.M., Van Der Meer, J. & Büller, H.R. (2005) Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. Journal of Thrombosis and Haemostasis, 3, 7984.
  • Bertina, R.M., Koeleman, B.P., Koster, T., Roosendaal, F.R., Dirven, R.J., De Ronde, H., Van Der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 6467.
  • Brouwer, J.L.P., Veeger, N.J.G.M., Kluin-Nelemans, H.C. & Van Der Meer, J. (2006) Multicausal pathogenesis of venous thromboembolism. Evidence from a study in families with hereditary deficiencies of protein S, protein C or Antithrombin. Annals of Internal Medicine, 145, 807815
  • Conard, J., Horellou, M.H., Van Dreden, P., Lecompte, T. & Samama, M. (1990) Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thrombosis and Haemostasis, 63, 319320.
  • Danneberg, J., Abbes, A.P., Bruggeman, B.J., Engel, H., Gerrits, J. & Martens, A. (1998) Reliable genotyping of the G-20210-A mutation of coagulation factor II (prothrombin). Clinical Chemistry, 44, 349351.
  • De Stefano, V., Leone, G., Mastrangelo, S., Tripodi, A., Rodeghiero, F., Castaman, G., Barbui, T., Finazzi, G., Bizzi, B. & Mannucci, P.M. (1994) Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S. Thrombosis and Haemostasis, 71, 799800.
  • Den Heijer, M., Blom, H.J., Gerrits, W.B.J., Roosendaal, F.R., Haak, H.L., Wijermans, P.W. & Bos, G.M. (1995) Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet, 345, 882885.
  • Den Heijer, M., Koster, T., Blom, H.J., Bos, G.M., Briet, E., Reitsma, P.H., Vandenbroucke, J.P. & Rosendaal, F.R. (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine, 344, 759761.
  • Frezzato, M., Tosetto, A. & Rodeghiero, F. (1996) Validated questionnaire for the identification of previous personal or familial venous thromboembolism. American Journal of Epidemiology, 143, 12571265.
  • Friederich, P.W., Sanson, B.J., Simioni, P., Zanardi, S., Huisman, M.V., Kindt, I., Prandoni, P., Buller, H.R., Girolami, A. & Prins, M.H. (1996) Frequency of pregnancy-related venous thromboembolism in anticoagulant factor- deficient women: implications for prophylaxis. Annals of Internal Medicine, 125, 955960.
  • Heijboer, H., Brandjes, D.P., Büller, H.R., Sturk, A. & Ten Cate, J.W. (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. New England Journal of Medicine, 323, 15121516.
  • Heit, J.A., Kobbervig, C.E., James, A.H., Petterson, T.M., Bailey, K.R. & Melton, III, L.J. (2005) Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Annals of Internal Medicine, 143, 697706.
  • Hellgren, M., Svensson, P.J. & Dahlback, B. (1995) Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. American Journal of Obstetrics and Gynecology, 73, 210213.
  • Van Hylckama Vlieg, A., Van Der Linden, I.K., Bertina, R.M. & Rosendaal, F.R. (2000) High levels of factor IX increase the risk of venous thrombosis. Blood, 95, 36783682.
  • Libourel, E.J., Bank, I., Meinardi, J.R., Balje-Volkers, C.P., Hamulyak, K., Middeldorp, S., Koopman, M.M., Van Pampus, E.C., Prins, M.H., Buller, H.R. & Van Der Meer, J. (2002) Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism. Haematologica, 87, 10681073.
  • Meijers, J.C., Tekelenburg, W.L., Bouma, B.N., Bertina, R.M., Rosendaal, F.R. & Nordström, M. (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. New England Journal of Medicine, 342, 696701
  • Nordström, M., Lindblad, B., Bergqvist, D. & Kjellstrom, T. (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. Journal of Internal Medicine, 232, 155160.
  • Pabinger, I. & Schneider, B. (1996) Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 742748.
  • Ray, J.G. & Chan, W.S. (1999) Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstetrical & Gynecological Survey, 54, 265271.
  • Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G.D., Walker, I.D., Greaves, M., Brenkel, I., Regan, L. & Greer, I.A. (2006) The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132, 171196.
  • Rochat, R.W., Koonin, L.M., Atrash, H.K. & Jewett, J.F. (1988) Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstetrics and Gynecology, 72, 9197.
  • Rothman, K.J. & Greenland, S. (1998) Modern Epidemiology. Lippincott-Raven Publishers, Philadelphia, PA.
  • Sanson, B.J., Simioni, P., Tormene, D., Moia, M., Friederich, P.W., Huisman, M.V., Prandoni, P., Bura, A., Rejto, L., Wells, P., Mannucci, P.M., Girolami, A., Buller, H.R. & Prins, M.H. (1999) The incidence of venous thromboembolism in symptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood, 94, 37023706.
  • Stirling, Y., Woolf, L., North, W.R., Seghatchian, M.J. & Meade, T.W. (1984) Haemostasis in normal pregnancy. Thrombosis and Haemostasis, 52, 7682.
  • Toglia, M.R. & Weg, J.G. (1996) Venous thromboembolism during pregnancy. New England Journal of Medicine, 335, 108114.